Picture of Humanigen logo

HGENQ Humanigen Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Humanigen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-12-10.3-89.5-237-70.7
Depreciation
Non-Cash Items5.523.542.495.935.81
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.2552.7517.246.7-11.8
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-6.21-4-69.9-184-76.7
Capital Expenditures-0.020
Purchase / Acquisition of Intangibles
Cash from Investing Activities-0.020
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities6.263.3313718616.8
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.047-0.67167.62.28-59.9